Retrospective Trials

In Progess

Study: Brain Metastasis from Cholangiocarcinoma 
PI: Yavuz Samanci 
IRRF Member: Selcuk Peker 
IRRF Center: Koc University 

Study: Radiosurgery for Pleomorphic Xanthoastrocytoma  
PI: Yavuz Samanci 
IRRF Member: Selcuk Peker 
IRRF Center: Koc University 

Study: Stereotactic radiosurgery for hemangioblastoma  
PI: Ahmed Shaaban 
IRRF Member: Sheehan 
IRRF Center: UVA 

Study: Assessing outcomes after SRS in patients with tumor-related TN 
PI: Timoteo Almeida 
IRRF Member: Carolina Benjamin 
IRRF Center: UMiami 

Study: Proposal for IRRF and CONDOR low-grade dAVFs Project 
PI: Ching-Jen Chen 
IRRF Member: Ching-Jen Chen 
IRRF Center: UTexas 

Study: Dosimetric Predictors of Toxicity for Brainstem Mets, AVMs, and large VS 
PI: Raj Singh 
IRRF Member: Sheehan 
IRRF Center: UVA 

Study: Calculate Dose Rate from the “SEALED SOURCE TEST CERTIFICATE”: 
PI: Tanxia Qu 
IRRF Member: Kondziolka 
IRRF Center: NYU 

Study: ​Brain Metastases from Sarcoma Primaries 
PI: Raj Singh 
IRRF Member: Sheehan 
IRRF Center: UVA 

Study: Safety and Efficacy of a Third SRS for Recurrent Trigeminal Neuralgia  
PI: Fernando 
IRRF Member: Sheehan 
IRRF Center: UVA 

Study: SRS for Pituitary Metastases 
PI: Sam 
IRRF Member: Lunsford 
IRRF Center: UPMC 

Closed Retrospective Trials

Re-irradiation with SRS after local or marginal recurrence (Roman O. Kowalchuk)

SRS for prostate Cancer Brain Metastases (Roy C. Bliley)

SRS for asymptomatic meningioma (Stylianos Pikis)

SRS for Bladder Cancer Brain Metastases (Rémi Perron)

SRS for Rathke's cleft cyst (Douglas Kondziolka)

Tumor control and Hearing outcomes after SRS for VS in NF-2 (Andrew Faramand)

SRS for Metastases  from triple negative breast cancer (Roman O. Kowalchuk)

SRS for Metastases  from HER2-positive breast cancer (Roman O. Kowalchuk)

Prognostic role of MGMT methylation and IDH mutation on SRS for GBM (Adomas Bunevicius)

Chronic expanding hematoma after AVM SRS (Hussam Abou-Al-Shaar)

Outcome Analysis of Gamma Knife Radiosurgery for Tremor (Ajay Niranjan)

SRS for Metastatic Orbital Tumors (Ajay Niranjan)

SRS for Ganglioglioma (Joshua Diamond)

Combined SRS and TKIs for Metastatic Mutation-Positive NSCLC (Chad G. Rusthoven)

SRS and Immune Checkpoint Inhibition for brain metastases (Eric J. Lehrer)